Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Fariba Fouladi, Lutz B. Jehn, Stephan K. Metzelder, Florian Hub, Katharina Henkenius, Andreas Burchert, Cornelia Brendel, Thorsten Stiewe & Andreas Neubauer. (2015) Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation. Leukemia & Lymphoma 56:9, pages 2690-2698.
Read now
Read now
Oytun Erbas, Halil Gursoy Pala, Emel Ebru Pala, Burcu Artunc Ulkumen, Levent Akman, Tulay Akman, Fatih Oltulu, Huseyin Aktug & Altug Yavasoglu. (2015) Therapeutic effect of sunitinib on diabetes mellitus related ovarian injury: an experimental rat model study. Gynecological Endocrinology 31:5, pages 388-391.
Read now
Read now
H. G. Pala, O. Erbas, E. E. Pala, B. Artunc Ulkumen, L. Akman, T. Akman, F. Oltulu & A. Yavasoglu. (2015) The effects of sunitinib on endometriosis. Journal of Obstetrics and Gynaecology 35:2, pages 183-187.
Read now
Read now
Osmond J D'Cruz & Fatih M Uckun. (2013) Protein kinase inhibitors against malignant lymphoma. Expert Opinion on Pharmacotherapy 14:6, pages 707-721.
Read now
Read now
Hong Zhang, Fu-Ming Zhang & Shi-Jun Yan. (2012) Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles. International Journal of Nanomedicine 7, pages 2901-2910.
Read now
Read now
Christoph Röllig, Christian Brandts, Shabnam Shaid, Marcus Hentrich, Alwin Krämer, Christian Junghanß, Eberhard Schleyer, Carsten Müller-Tidow, Wolfgang E. Berdel, Barbara Ritter, Karl-Heinz Pflüger, Michael Kramer, Martina Haibach, Gerhard Ehninger, Hubert Serve & Stefan W. Krause. (2012) Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemia. Leukemia & Lymphoma 53:6, pages 1062-1067.
Read now
Read now
Hillary Prescott, Hagop Kantarjian, Jorge Cortes & Farhad Ravandi. (2011) Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia. Expert Opinion on Emerging Drugs 16:3, pages 407-423.
Read now
Read now
Articles from other publishers (33)
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny & Hamada S. Abulkhair. (2022) The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia. Bioorganic Chemistry 127, pages 105968.
Crossref
Crossref
Elli D. Novatcheva, Yasmine Anouty, Ila Saunders, James K. Mangan & Aaron M. Goodman. (2022) FMS-Like Tyrosine Kinase 3 Inhibitors for the Treatment of Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 22:3, pages e161-e184.
Crossref
Crossref
Xizhong Song, Xiaoyu Liu, Wei Yu & Yi Jin. (2021) Amide-Assisted Rearrangement of Hydroxyarylformimidoyl Chloride to Diarylurea. Molecules 26:21, pages 6437.
Crossref
Crossref
Motoki Eguchi, Yosuke Minami, Ayumi Kuzume & SungGi Chi. (2020) Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia. Biomedicines 8:8, pages 245.
Crossref
Crossref
Arun K. Ghosh & Margherita Brindisi. (2019) Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry. Journal of Medicinal Chemistry 63:6, pages 2751-2788.
Crossref
Crossref
Abdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, Mohamad Mohty & Ali Bazarbachi. (2019)
Allogeneic transplant for
FLT3
-
ITD
mutated AML: a focus on
FLT3
inhibitors before, during, and after transplant
. Therapeutic Advances in Hematology 10, pages 204062071988266.
Crossref
Crossref
Andrzej Lange, Emilia Jaskula, Janusz Lange, Grzegorz Dworacki, Dorota Nowak, Aleksandra Simiczyjew, Monika Mordak-Domagala & Mariola Sedzimirska. (2018) The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow. PLOS ONE 13:1, pages e0190525.
Crossref
Crossref
Andrea N. Edginton, Eric I. Zimmerman, Aksana Vasilyeva, Sharyn D. Baker & John C. Panetta. (2016) Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice. Cancer Chemotherapy and Pharmacology 77:5, pages 1039-1052.
Crossref
Crossref
Kendra Sweet & Jeffrey E. Lancet. (2014) Novel Therapeutics in Acute Myeloid Leukemia. Current Hematologic Malignancy Reports 9:2, pages 109-117.
Crossref
Crossref
Giulia Fontanelli, Melania Rocco, Francesco Caracciolo, Edoardo Benedetti, Gabriele Buda, Enrico Orciuolo, Giovanni Carulli, Sara Galimberti, Antonio Azzarà & Mario Petrini. (2014) Sorafenib As Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 14:1, pages e13-e17.
Crossref
Crossref
Chang-Fang Wang, Ermei M. Mäkilä, Martti H. Kaasalainen, Dongfei Liu, Mirkka P. Sarparanta, Anu J. Airaksinen, Jarno J. Salonen, Jouni T. Hirvonen & Hélder A. Santos. (2014) Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake. Biomaterials 35:4, pages 1257-1266.
Crossref
Crossref
Fariba Navid, Robbin Christensen, Hiroto Inaba, Lie Li, Zhaoyuan Chen, Xiangjun Cai, Joshua Regel & Sharyn D. Baker. (2013) Alternative formulations of sorafenib for use in children. Pediatric Blood & Cancer 60:10, pages 1642-1646.
Crossref
Crossref
Hubert ServeUtz KrugRuth WagnerM. Cristina SauerlandAchim HeineckeUta BrunnbergMarkus SchaichOliver OttmannJustus DuysterHannes WandtThomas FischerAristoteles GiagounidisAndreas NeubauerAlbrecht ReichleWalter AulitzkyRichard NoppeneyIgor BlauVolker KunzmannReingard StuhlmannAlwin KrämerKarl-Anton KreuzerChristian BrandtsBjörn SteffenChristian ThiedeCarsten Müller-TidowGerhard EhningerWolfgang E. Berdel. (2013) Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial. Journal of Clinical Oncology 31:25, pages 3110-3118.
Crossref
Crossref
Eric I. Zimmerman, Justin L. Roberts, Lie Li, David Finkelstein, Alice Gibson, Amarjit S. Chaudhry, Erin G. Schuetz, Jeffrey E. Rubnitz, Hiroto Inaba & Sharyn D. Baker. (2012) Ontogeny and Sorafenib Metabolism. Clinical Cancer Research 18:20, pages 5788-5795.
Crossref
Crossref
Tanya C. Watt & Todd Cooper. (2012) Sorafenib as treatment for relapsed or refractory pediatric acute myelogenous leukemia. Pediatric Blood & Cancer 59:4, pages 756-757.
Crossref
Crossref
Ursula Creutzig. 2013. Childhood Leukemias. Childhood Leukemias
421
428
.
Manish Sharma, Farhad Ravandi, Ulas Darda Bayraktar, Alexandre Chiattone, Qaiser Bashir, Sergio Giralt, Julianne Chen, Muzaffar Qazilbash, Partow Kebriaei, Marina Konopleva, Michael Andreeff, Jorge Cortes, Deborah McCue, Hagop Kantarjian, Richard E. Champlin & Marcos de Lima. (2011) Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib. Biology of Blood and Marrow Transplantation 17:12, pages 1874-1877.
Crossref
Crossref
Robert J. Davies, Albert C. Pierce, Cornelia Forster, Ron Grey, Jinwang Xu, Michael Arnost, Deborah Choquette, Vincent Galullo, Shi-Kai Tian, Greg Henkel, Guanjing Chen, David K. Heidary, Joanne Ma, Cameron Stuver-Moody & Mark Namchuk. (2011) Design, Synthesis, and Evaluation of a Novel Dual Fms-Like Tyrosine Kinase 3/Stem Cell Factor Receptor (FLT3/c-KIT) Inhibitor for the Treatment of Acute Myelogenous Leukemia. Journal of Medicinal Chemistry 54:20, pages 7184-7192.
Crossref
Crossref
Hiroto InabaJeffrey E. RubnitzElaine Coustan-SmithLie LiBrian D. FurmanskiGerard P. MascaraKenneth M. HeymRobbin ChristensenMihaela OnciuSheila A. ShurtleffStanley B. PoundsChing-Hon PuiRaul C. RibeiroDario CampanaSharyn D. Baker. (2011) Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia. Journal of Clinical Oncology 29:24, pages 3293-3300.
Crossref
Crossref
Aref Al-Kali, Jorge Cortes, Stefan Faderl, Dan Jones, Caroline Abril, Sherry Pierce, Mark Brandt, Hagop Kantarjian & Farhad Ravandi. (2011) Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 11:4, pages 361-366.
Crossref
Crossref
Shuiying Hu, Hongmei Niu, Hiroto Inaba, Shelley Orwick, Charles Rose, John C. Panetta, Shengping Yang, Stanley Pounds, Yiping Fan, Christopher Calabrese, Jerold E. Rehg, Dario Campana, Jeffrey E. Rubnitz & Sharyn D. Baker. (2011) Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia. JNCI: Journal of the National Cancer Institute 103:11, pages 893-905.
Crossref
Crossref
Sebastian Scholl, Baerbel Spies-Weisshart, Anne Klink, Lars-Olof Muegge, Hans-Joerg Fricke & Andreas Hochhaus. (2010) Secondary resistance to sorafenib in two patients with acute myeloid leukemia (AML) harboring FLT3-ITD mutations. Annals of Hematology 90:4, pages 473-475.
Crossref
Crossref
Gang Wei, Meifang Wang, Terry Hyslop, Ziqiu Wang & Brian I. Carr. (2010)
Vitamin K enhancement of sorafenib‐mediated HCC cell growth inhibition
in vitro
and
in vivo
. International Journal of Cancer 127:12, pages 2949-2958.
Crossref
Crossref
Lie Li, Ming Zhao, Fariba Navid, Keith Pratz, B. Doug Smith, Michelle A. Rudek & Sharyn D. Baker. (2010) Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography–tandem mass spectrometry. Journal of Chromatography B 878:29, pages 3033-3038.
Crossref
Crossref
Deepika Lal, Jennifer A. Park, Kellie Demock, Joseph Marinaro, Amanda M. Perez, Mei-Hui Lin, Lili Tian, Terry J. Mashtare, Michael Murphy, Joshua Prey, Meir Wetzler, Gerald J. Fetterly & Eunice S. Wang. (2010)
Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy
In vivo
in Human Acute Myeloid Leukemia Models
. Molecular Cancer Therapeutics 9:10, pages 2737-2751.
Crossref
Crossref
Rehan Ahmad, Suiyang Liu, Ellen Weisberg, Erik Nelson, Ilene Galinsky, Colin Meyer, Donald Kufe, Surender Kharbanda & Richard Stone. (2010) Combining the FLT3 Inhibitor PKC412 and the Triterpenoid CDDO-Me Synergistically Induces Apoptosis in Acute Myeloid Leukemia with the Internal Tandem Duplication Mutation. Molecular Cancer Research 8:7, pages 986-993.
Crossref
Crossref
Farhad Ravandi, Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Susan O?Brien, Charles Koller, Sherry Pierce, Mark Brandt, Deborah Kennedy, Jorge Cortes & Miloslav Beran. (2010) Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse. Leukemia Research 34:6, pages 752-756.
Crossref
Crossref
Susanne C. Miller, Ruili Huang, Srilatha Sakamuru, Sunita J. Shukla, Matias S. Attene-Ramos, Paul Shinn, Danielle Van Leer, William Leister, Christopher P. Austin & Menghang Xia. (2010) Identification of known drugs that act as inhibitors of NF-κB signaling and their mechanism of action. Biochemical Pharmacology 79:9, pages 1272-1280.
Crossref
Crossref
Farhad RavandiJorge E. CortesDaniel JonesStefan FaderlGuillermo Garcia-ManeroMarina Y. KonoplevaSusan O'BrienZeev EstrovGautam BorthakurDeborah ThomasSherry R. PierceMark BrandtAnna ByrdB. Nebiyou BekeleKeith PratzRajyalakshmi LuthraMark LevisMichael AndreeffHagop M. Kantarjian. (2010) Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia. Journal of Clinical Oncology 28:11, pages 1856-1862.
Crossref
Crossref
Gary J. SchillerSusan M. O'BrienArnaud PigneuxDaniel J. DeAngeloNorbert VeyJonathan KellScott SolomonRobert K. StuartVerena KarstenAnn L. CahillMaher X. AlbitarFrancis J. Giles. (2010) Single-Agent Laromustine, A Novel Alkylating Agent, Has Significant Activity in Older Patients With Previously Untreated Poor-Risk Acute Myeloid Leukemia. Journal of Clinical Oncology 28:5, pages 815-821.
Crossref
Crossref
Farhad Ravandi. 2010. Neoplastic Hematopathology. Neoplastic Hematopathology
165
176
.
Shuiying Hu, Zhaoyuan Chen, Ryan Franke, Shelley Orwick, Ming Zhao, Michelle A. Rudek, Alex Sparreboom & Sharyn D. Baker. (2009) Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters. Clinical Cancer Research 15:19, pages 6062-6069.
Crossref
Crossref
Stephan MetzelderYing WangEllen WollmerMichael WanzelSabine TeichlerAnuhar ChaturvediMartin Eilers, Erich Enghofer, Andreas NeubauerAndreas Burchert. (2009) Compassionate use of sorafenib in FLT3-ITD–positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation. Blood 113:26, pages 6567-6571.
Crossref
Crossref